Why the study?
Does treatment with drug-eluting stents reduce mortality rates compared to Coronary-Artery Bypass Grafting in patients with multivessel disease?
Does treatment with drug-eluting stents reduce mortality rates compared to Coronary-Artery Bypass Grafting in patients with multivessel disease?
In patients with multivessel coronary disease, CABG remains superior to drug-eluting stents in reducing mortality, myocardial infarction, and the need for repeat revascularization.
No takes yet. Share an insight, caveat, or question.
May support CABG preference in multivessel disease; leaves open confirmation by contemporary randomized trials.
Hannan et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: